Aisling Capital Management LP Portfolio Holdings
Aisling Capital Management LP
- $292 Million
- Q1 2024
Aisling Capital Management LP has filed its 13F form on May 14, 2024 for Q1 2024 where it was disclosed a total value porftolio of $292 Million distributed in 16 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Bridge Bio Pharma, Inc. with a value of $188M, Syndax Pharmaceuticals Inc with a value of $24.4M, Verona Pharma PLC with a value of $17.9M, Elevation Oncology, Inc. with a value of $14.5M, and Biomea Fusion, Inc. with a value of $11.9M.
Examining the 13F form we can see an decrease of $41.1M in the current position value, from $333M to 292M.
Aisling Capital Management LP is based out at New York, NY
Below you can find more details about Aisling Capital Management LP portfolio as well as his latest detailed transactions.